Literature DB >> 16278853

APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Oye Gureje1, Adesola Ogunniyi, Olusegun Baiyewu, Brandon Price, Frederick W Unverzagt, Rebecca M Evans, Valerie Smith-Gamble, Kathleen A Lane, Sujuan Gao, Kathleen S Hall, Hugh C Hendrie, Jill R Murrell.   

Abstract

Since 1992, research teams from Indiana University and the University of Ibadan have been collecting and comparing data from two diverse, elderly populations to identify risk factors for dementia and Alzheimer's disease. Apolipoprotein E (APOE) was genotyped in 2,245 Nigerian samples. Of these, 830 had a diagnosis: 459 were normal, and 140 had dementia including 123 diagnosed with Alzheimer's disease. In contrast with other populations, the APOE epsilon4 allele was not significantly associated with Alzheimer's disease or dementia. This lack of association in the Yoruba might reflect genetic variation, environmental factors, as well as genetic/environmental interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16278853      PMCID: PMC2855121          DOI: 10.1002/ana.20694

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  The US economic and social costs of Alzheimer's disease revisited.

Authors:  R L Ernst; J W Hay
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

4.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

Authors:  Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider
Journal:  Arch Neurol       Date:  2003-02

5.  The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

Authors:  M X Tang; Y Stern; K Marder; K Bell; B Gurland; R Lantigua; H Andrews; L Feng; B Tycko; R Mayeux
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

6.  Community screening interview for dementia (CSI 'D'); performance in five disparate study sites.

Authors:  K S Hall; S Gao; C L Emsley; A O Ogunniyi; O Morgan; H C Hendrie
Journal:  Int J Geriatr Psychiatry       Date:  2000-06       Impact factor: 3.485

7.  Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.

Authors:  H C Hendrie; A Ogunniyi; K S Hall; O Baiyewu; F W Unverzagt; O Gureje; S Gao; R M Evans; A O Ogunseyinde; A O Adeyinka; B Musick; S L Hui
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Care arrangements for people with dementia in developing countries.

Authors:  Martin Prince
Journal:  Int J Geriatr Psychiatry       Date:  2004-02       Impact factor: 3.485

10.  Apolipoprotein E and mortality in African-Americans and Yoruba.

Authors:  Kathleen A Lane; Sujuan Gao; Siu L Hui; Jill R Murrell; Kathleen S Hall; Hugh C Hendrie
Journal:  J Alzheimers Dis       Date:  2003-10       Impact factor: 4.472

View more
  44 in total

1.  Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease.

Authors:  Vincenzo De Luca; Maria Donata Orfei; Sara Gaudenzi; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-12-29       Impact factor: 5.270

2.  Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease.

Authors:  Yong Ji; Mengyuan Liu; Ya Ruth Huo; Shuling Liu; Zhihong Shi; Shuai Liu; Thomas Wisniewski; Jinhuan Wang
Journal:  Dement Geriatr Cogn Disord       Date:  2013-07-23       Impact factor: 2.959

Review 3.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

4.  The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Authors:  Sterling C Johnson; Taylor W Schmitz; Mehul A Trivedi; Michele L Ries; Britta M Torgerson; Cynthia M Carlsson; Sanjay Asthana; Bruce P Hermann; Mark A Sager
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

Review 5.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

6.  APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.

Authors:  Hugh C Hendrie; Jill Murrell; Olusegun Baiyewu; Kathleen A Lane; Christianna Purnell; Adesola Ogunniyi; Frederick W Unverzagt; Kathleen Hall; Christopher M Callahan; Andrew J Saykin; Oye Gureje; Ann Hake; Tatiana Foroud; Sujuan Gao
Journal:  Int Psychogeriatr       Date:  2014-02-24       Impact factor: 3.878

7.  GAB2 is not associated with late-onset Alzheimer's disease in Japanese.

Authors:  Akinori Miyashita; Hiroyuki Arai; Takashi Asada; Masaki Imagawa; Mikio Shoji; Susumu Higuchi; Katsuya Urakami; Shinichi Toyabe; Kohei Akazawa; Ichiro Kanazawa; Yasuo Ihara; Ryozo Kuwano
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

8.  Using genetics to enable studies on the prevention of Alzheimer's disease.

Authors:  D G Crenshaw; W K Gottschalk; M W Lutz; I Grossman; A M Saunders; J R Burke; K A Welsh-Bohmer; S K Brannan; D K Burns; A D Roses
Journal:  Clin Pharmacol Ther       Date:  2012-11-07       Impact factor: 6.875

9.  Association of apolipoprotein E genotype and Alzheimer disease in African Americans.

Authors:  Jill R Murrell; Brandon Price; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Adesola Ogunniyi; Frederick W Unverzagt; Valerie Smith-Gamble; Sujuan Gao; Hugh C Hendrie; Kathleen S Hall
Journal:  Arch Neurol       Date:  2006-03

10.  Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention?

Authors:  Ivar Reinvang; Ian J Deary; Anders M Fjell; Vidar M Steen; Thomas Espeseth; Raja Parasuraman
Journal:  Front Aging Neurosci       Date:  2010-11-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.